AnalystsWilliam Pickering
William Pickering's Stock Forecasts

Analyst Ranking
Top 45%
#2461 out of 5510 analysts
Average Return
+0.49%
Win Rate
56%14 out of 25
Risk vs Reward
Poor
Good

William Pickering's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Alnylam Pharmaceuticals IncALNY
+72.24%$235.95$406.40
2025-01-07 -
2026-01-06
Buy
Vertex Pharmaceuticals IncVRTX
+41.12%$358.40$505.78
2023-08-02 -
2024-08-01
Buy
Vertex Pharmaceuticals IncVRTX
+39.88%$354.05$495.26
2023-07-28 -
2024-07-26
Buy
Regeneron Pharmaceuticals IncREGN
+38.82%$586.96$814.79
2025-08-27 -
2026-08-26
Buy
Vertex Pharmaceuticals IncVRTX
+36.16%$302.66$412.11
2023-03-21 -
2024-03-20
Buy

William Pickering Analyst Color

Get additional color on William Pickering's coverage of popular stocks

William Pickering's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Intellia Therapeutics IncNTLA
3Hold$17.00+44.80%Maintains
4 months ago
Dyne Therapeutics IncDYN
1Hold$24.00+31.80%Maintains
4 months ago
Crispr Therapeutics AgCRSP
2Hold$56.00+8.28%Maintains
4 months ago
Beam Therapeutics IncBEAM
3Buy$39.00+62.57%Maintains
4 months ago
Arrowhead Pharmaceuticals IncARWR
3Hold$46.00-44.48%Maintains
4 months ago
Biomarin Pharmaceutical IncBMRN
7Buy$82.00+24.85%Maintains
4 months ago
Vertex Pharmaceuticals IncVRTX
7Buy$572.00+10.97%Maintains
4 months ago
Allogene Therapeutics IncALLO
3Hold$3.85+116.29%Maintains
5 months ago
Regeneron Pharmaceuticals IncREGN
4Buy$921.00+17.85%Maintains
5 months ago
Bridgebio Pharma IncBBIO
1Buy$94.00+29.76%Initiates Coverage On
9 months ago
Biohaven LtdBHVN
3Hold$9.00-29.19%Downgrades
10 months ago
Biogen IncBIIB
1Hold$157.00-27.70%Maintains
10 months ago
Avidity Biosciences IncRNAM
1Hold$72.00+388.14%Downgrades
a year ago
Sarepta Therapeutics IncSRPT
1Hold$13.00N/AInitiates Coverage On
a year ago
Alnylam Pharmaceuticals IncALNY
2Buy$310.00N/AMaintains
2 years ago
Ionis Pharmaceuticals IncIONS
2HoldN/AN/AUpgrades
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.